A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus

Laing, Josh (Primary Chief Investigator (PCI))
Carney, Patrick (Chief Investigator (CI))
D'Souza, Wendyl Jude (Chief Investigator (CI))
Leditschke, Isabel Anne (Chief Investigator (CI))
Deane, Adam (Chief Investigator (CI))
Somerville, Ernest Robertson (Chief Investigator (CI))

Department of Neuroscience

Project: Research

Status	Finished
Effective start/end date	5/05/23 → 4/05/25

Keywords

Clinical Trials
ganaxolone

Clinical Trial Phase

Phase III (a & b)